View : 15 Download: 1

Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine

Title
Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine
Authors
Lee C.K.Kim H.-S.Ye B.D.Lee K.-M.Kim Y.S.Rhee S.Y.Kim H.-J.Yang S.-K.Moon W.Koo J.-S.Lee S.-H.Seo G.S.Park S.J.Choi C.H.Jung S.-A.Hong S.N.Im J.P.Kim E.S.
Ewha Authors
정성애
SCOPUS Author ID
정성애scopus
Issue Date
2014
Journal Title
Journal of Crohn's and Colitis
ISSN
1876-4479JCR Link
Citation
vol. 8, no. 5, pp. 384 - 391
Publisher
Elsevier
Indexed
SCOPUS WOS scopus
Abstract
Crohn's disease; Immunosuppressive agents; Inflammatory bowel disease; Pneumococcal vaccine
DOI
10.1016/j.crohns.2013.09.022
Appears in Collections:
의학전문대학원 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE